Cargando…
Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
Glucagon-like peptide-1 (GLP-1) is an insulin-releasing hormone clinically exploited for glycaemic control in diabetes, which also confers acute cardioprotection and benefits in experimental/clinical heart failure. We specifically investigated the role of the GLP-1 mimetic, exendin-4, in post-myocar...
Autores principales: | Robinson, Emma, Cassidy, Roslyn S., Tate, Mitchel, Zhao, Youyou, Lockhart, Samuel, Calderwood, Danielle, Church, Rachel, McGahon, Mary K., Brazil, Derek P., McDermott, Barbara J., Green, Brian D., Grieve, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344953/ https://www.ncbi.nlm.nih.gov/pubmed/25725809 http://dx.doi.org/10.1007/s00395-015-0476-7 |
Ejemplares similares
-
Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
por: Tate, Mitchel, et al.
Publicado: (2015) -
Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling
por: Robinson, Emma, et al.
Publicado: (2016) -
Quality assurance in 3D-printing: A dimensional accuracy study of patient-specific 3D-printed vascular anatomical models
por: Nguyen, Philip, et al.
Publicado: (2023) -
Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling
por: Pastel, E, et al.
Publicado: (2016) -
Single-cell transcriptomic profiling provides insights into retinal endothelial barrier properties
por: Watson, Mark I., et al.
Publicado: (2020)